UBS Group’s T. Rowe Price Health Care ETF TMED Stock Holding History

UBS Group’s Portfolio TMED Stock Details TMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-52	Closed	-$1.55K	–	11615
2025 Q4	$1.55K	Buy	+52	New	+$1.51K	﹤0.01%	9541

Other funds holding TMED

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

UBS Group's TMED Position: Q1 2026 in Review

UBS Group sold out of T. Rowe Price Health Care ETF (TMED) in Q1 2026, closing a stake of 52 shares — an estimated $1.55K sold.

UBS Group first reported a position in TMED in Q4 2025 and held it in 1 quarter. The position peaked at $1.55K in Q4 2025. 4 funds tracked by Wall St. Rank hold TMED as of Q1 2026.

UBS Group reported no remaining T. Rowe Price Health Care ETF position as of Q1 2026 after selling out during the quarter.
UBS Group sold 52 T. Rowe Price Health Care ETF shares in Q1 2026, an estimated $1.55K.
UBS Group first reported a position in T. Rowe Price Health Care ETF in Q4 2025 and held it in 1 quarter.
UBS Group's T. Rowe Price Health Care ETF position peaked at $1.55K in Q4 2025.
4 funds tracked by Wall St. Rank held T. Rowe Price Health Care ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.